eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ALNY-Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc ALNY

$453.61-0.57(-0.13%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Alnylam Pharmaceuticals Inc
Today
Create an eToro account to buy ALNY stock on a secure, user-friendly, multi-asset trading platform.
Buy Alnylam Pharmaceuticals Inc
Buy Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc ALNY
Buy ALNY
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
441.55
Based on analysts who covered ALNY

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Alnylam Pharmaceuticals Inc News

About Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc is a speciality biopharmaceutical company based in Cambridge, Massachusetts. The firm was founded by a group of dedicated scientists and was incorporated in Delaware in 2002. It has offices around the globe, including the UK, Germany, Italy, Sweden, Japan and Brazil. The focus of Alnylam’s research is the science of RNAi (RNA interference) and to transform the lives of patients suffering from chronic diseases.

The company went public in May 2004 and is traded on the NASDAQ, under the ticker ALNY. As of August 2020, the ALNY stock chart showed a 52-week high of $167.33 and a 52-week low of $73.32. In 2020, the firm employed over 1,400 full-time members of staff. Alnylam revenue for the 12 months ending the 30th June 2020 showed a year-over-year increase of 241.39%.

Alnylam Pharmaceuticals continues to grow and innovate with a strong focus on research and development. The company focuses on continual innovation in order to improve the lives of individuals living with diseases which only have limited treatment options.

Diversify your investments today with this medical innovator, and add ALNY stock to your eToro portfolio.
VIEW MORE   

ALNY Stock Price Chart

‎37.42‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Alnylam Pharmaceuticals Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Alnylam Pharmaceuticals Inc share price today is $453.61, reflecting a ‎-0.13‎% change over the last 24 hours and ‎-2.89‎% over the past week. The current market capitalization of ALNY is $59.53B with an average volume in the last three months of 1.08M. The stock has a P/E ratio of -184.1 and a dividend yield of 0%. With the stock’s beta sitting at 0.94
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$59.53B
Day’s Range
i
Shows the high and low prices of the day.
$449.33 - $455.51
52W Range
i
Shows the high and low prices of the last year.
$142.71 - $468.43
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.08M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-184.1
Revenue
i
The total income generated by this company’s goods and services last year.
$2.46B
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
$0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$454.18
EPS
i
A company’s total earnings divided by the number of shares it has issued.
$-2.47
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.94
What Is Alnylam Pharmaceuticals Inc?
Alnylam Pharmaceuticals Inc is a speciality biopharmaceutical company based in Cambridge, Massachusetts. The firm was founded by a group of dedicated scientists and was incorporated in Delaware in 2002. It has offices around the globe, including the UK, Germany, Italy, Sweden, Japan and Brazil. The focus of Alnylam’s research is the science of RNAi (RNA interference) and to transform the lives of patients suffering from chronic diseases.

The company went public in May 2004 and is traded on the NASDAQ, under the ticker ALNY. As of August 2020, the ALNY stock chart showed a 52-week high of $167.33 and a 52-week low of $73.32. In 2020, the firm employed over 1,400 full-time members of staff. Alnylam revenue for the 12 months ending the 30th June 2020 showed a year-over-year increase of 241.39%.

Alnylam Pharmaceuticals continues to grow and innovate with a strong focus on research and development. The company focuses on continual innovation in order to improve the lives of individuals living with diseases which only have limited treatment options.

Diversify your investments today with this medical innovator, and add ALNY stock to your eToro portfolio.
Buy ALNY

How can I buy Alnylam Pharmaceuticals Inc stocks?

To purchase Alnylam Pharmaceuticals Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Alnylam Pharmaceuticals Inc (ALNY) page and place an order to buy Alnylam Pharmaceuticals Inc.
Buy ALNY
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Alnylam Pharmaceuticals Inc
Invest in Alnylam Pharmaceuticals Inc
Today
Create an eToro account to buy ALNY stock on a secure, user-friendly, multi-asset trading platform.
Buy ALNY

FAQ

The current price of ALNY is $453.61.
The average price target for Alnylam Pharmaceuticals Inc is $441.55. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Alnylam Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Alnylam Pharmaceuticals Inc is $59.53B
Based on 14 analysts offering recommendations for ALNY in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top